Could a gel help fight breast cancer? new trial tests endoxifen
NCT ID NCT03317405
First seen Apr 30, 2026 · Last updated May 20, 2026 · Updated 5 times
Summary
This early-phase trial is testing a gel form of the drug endoxifen on the breast skin of 32 women scheduled for mastectomy. The goal is to find the safest dose and see how much drug gets into breast tissue. The study compares the gel to a placebo to understand side effects and potential benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE II BREAST CANCER AJCC V6 AND V7 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.